Singular Genomics Systems, Inc. (OMIC)
NASDAQ: OMIC · Real-Time Price · USD
19.55
-0.42 (-2.10%)
Dec 20, 2024, 4:00 PM EST - Market closed
Singular Genomics Systems Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | -86.32 | -94.82 | -90.88 | -98.77 | -27.95 | -12.32 |
| Depreciation & Amortization | 6.85 | 7.22 | 6.03 | 1.13 | 0.64 | 0.35 |
| Other Amortization | 0.16 | 0.15 | 0.17 | 0.28 | 0.23 | - |
| Loss (Gain) From Sale of Assets | - | - | 0.06 | 0.09 | - | - |
| Asset Writedown & Restructuring Costs | 0.18 | 1.9 | - | - | - | - |
| Loss (Gain) From Sale of Investments | -2.33 | -1.12 | 0.68 | 1.87 | 0.08 | -0.01 |
| Stock-Based Compensation | 9.93 | 11.4 | 13.67 | 9.23 | 1.06 | 0.17 |
| Other Operating Activities | 0.43 | 3.86 | - | 37.38 | 0.2 | - |
| Change in Accounts Receivable | 0.22 | 0.35 | -0.91 | - | - | - |
| Change in Inventory | -4.22 | -3.54 | -13.49 | - | - | - |
| Change in Accounts Payable | 1.43 | 0.27 | -1.17 | 1.85 | -0.15 | 0.24 |
| Change in Other Net Operating Assets | -6.76 | 0.68 | -1.25 | -4.77 | 1.01 | 0.17 |
| Operating Cash Flow | -80.43 | -73.65 | -87.09 | -51.7 | -24.87 | -11.4 |
| Capital Expenditures | -0.43 | -0.97 | -6.02 | -4.86 | -1.38 | -0.8 |
| Investment in Securities | 98.91 | 14.78 | -33.54 | -126 | 25.39 | -30.7 |
| Investing Cash Flow | 98.49 | 13.81 | -39.57 | -130.86 | 24.01 | -31.5 |
| Long-Term Debt Issued | - | - | - | 141 | 7.5 | 2.46 |
| Long-Term Debt Repaid | - | - | - | -10.4 | - | - |
| Net Debt Issued (Repaid) | - | - | - | 130.6 | 7.5 | 2.46 |
| Issuance of Common Stock | 0.16 | 0.72 | 1.35 | 241.57 | 0.05 | 0.04 |
| Repurchase of Common Stock | -0.01 | -0.02 | -0.45 | -0.04 | - | - |
| Other Financing Activities | - | - | - | - | -0.03 | -0.2 |
| Financing Cash Flow | 0.15 | 0.7 | 0.9 | 372.13 | 7.52 | 47.3 |
| Net Cash Flow | 18.21 | -59.14 | -125.76 | 189.57 | 6.65 | 4.41 |
| Free Cash Flow | -80.86 | -74.62 | -93.12 | -56.57 | -26.25 | -12.2 |
| Free Cash Flow Margin | -3031.72% | -2563.28% | -12172.03% | - | - | - |
| Free Cash Flow Per Share | -32.57 | -30.75 | -39.26 | -36.09 | -74.47 | -42.46 |
| Cash Interest Paid | 0.99 | 0.94 | 0.56 | 0.57 | 0.46 | 0.01 |
| Levered Free Cash Flow | -37.99 | -36.81 | -59.47 | -36.23 | -15.81 | - |
| Unlevered Free Cash Flow | -37.43 | -36.27 | -59.16 | -35.98 | -15.6 | - |
| Change in Net Working Capital | -3.23 | -9.14 | 14.41 | 3.18 | -1.29 | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.